|
The
biopharma boom
The use of biotechnology has, in a short time, revolutionised
the pharmaceutical industry with its emergence as an effective
tool in the treatment of diseases. Sapna Dogra analyses the
potential of biopharmaceuticals to outperform the entire pharmaceutical
market.
Upfront
Merck's
Erbitux gets DCGI approval
Merck announced that it has received approval from the DCGI
for Erbitux, a new targeted cancer therapy drug. It is indicated
for the treatment of patients with locally-advanced squamous
cell carcinoma of the head and neck (SCCHN).
Glenmark
gets tentative approval for Ondansetron
Glenmark Pharmaceuticals, USA has received tentative approval
from the USFDA for its ANDA for Ondansetron Hydrochloride
Tablets of four milligram (base), eight milligram (base) and
24 milligram (base).
Ethypharm
licenses cardio product to Ranbaxy
Ethypharm India announced out-licensing and supply contract
agreements for a fixed dose combination of Fenofibrate micronized
160 milligram and Atorvastatin 10 milligram with Ranbaxy,
which will be launched in the Indian market.
Bilcare
buys clinical trial services company
Bilcare has acquired DHP, a UK-based clinical trials services
provider.
Shasun
signs manufacturing pact with Gilead
Shasun Chemicals and Drugs signed a non-exclusive licensing
agreement with Gilead Sciences for the manufacture and sale
of the generic version of Tenofovir Disoproxil Fumarate, using
Gilead's proprietary technology.
Claris
enters the Spanish market
Claris Lifesciences announced its entry into Spain by signing
a marketing agreement with Juste Pharmaceuticals.
High
end bioinformatics solution by NMITLI
The honourable Minister of Science and Technology and Earth
Sciences, Kapil Sibal launched Geno-cluster, a bioinformatics
software developed jointly by the Institute of Genomics and
Integrative Biology and Jalaja Technologies, under the New
Millennium Indian Technology Leadership Initiative (NMITLI)
programme.
'IndiaChem
has become a global event'
IndiaChem 2006, the much-awaited international conference
jointly organsied by FICCI and Department of Chemicals and
Petrochemicals, is scheduled to take place in Mumbai from
November 8-10, 2006. Rajan Kohli, Deputy Secretary General,
FICCI delineates its salient features to Sapna Dogra.
Technology
for biotechnology
When
industry champions meet
Organisation of Pharmaceutical Producers of India (OPPI) decided
to get all the stalwarts of the pharma industry at its AGM
meeting. In addition to the glitter, the occasion witnessed
the release of the 40th Annual OPPI report, election of the
office bearers for the year and felicitation of the OPPI award
winners.
A
school for the industry
This is for all those who have forgotten what a school laboratory
looks like and teachers who conduct tests! The participants
of the one-of-its-kind national workshop on chromatographic
separations, could experience demonstrations, quizzes and
question and answer sessions.
A
congregation of the industry, for the industry
What happens when the who's who of the industry come together?
They talk about challenges and discuss strategies to overcome
them. Aptly titled, Pharmaceutical Leadership Summit 2006,
the event witnessed a coming together of great minds of the
Indian pharma, who shared their views on topics that were
close to their hearts, with a view to make this knowledge
industry the next big thing for the country.
Upcoming
Events
|
